Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
US Market
Holding ARDS?
Track your performance easily

Aridis Pharmaceuticals (ARDS) Cash flow

209 Followers

Aridis Pharmaceuticals Cash Flow

ARDS's free cash flow for Q3 2023 was $-983.00K. For the 2023 fiscal year, ARDS's free cash flow was decreased by $-5.74M and operating cash flow was $-983.00K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -17.89M$ -29.13M$ -22.94M$ -20.48M$ -8.16M$ -24.27M
Investing Cash Flow
$ -35.00K$ -82.00K$ -530.00K$ -367.00K$ -174.00K$ -1.68M
Financing Cash Flow
$ 15.32M$ 14.78M$ 34.72M$ 8.68M$ 4.99M$ 25.09M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ -40.04M$ 5.56M$ 19.99M$ 8.73M$ 20.90M$ 24.24M
Income Tax Paid Supplemental Data
$ 22.00K$ 19.00K$ 2.00K$ 2.00K$ 2.00K$ 2.00K
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 3.79M--$ 7.95M$ 4.96M$ 25.08M
Issuance Of Debt
$ -335.00K$ 3.20M$ 5.00M$ 715.00K$ 0.00-
Repayment Of Debt
$ -2.83M$ -1.80M----
Free Cash Flow
$ -17.92M$ -29.21M$ -23.47M$ -20.84M$ -8.33M$ -24.95M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Aridis Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis